Cargando…
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients
Ursodeoxycholic acid (UDCA) was demonstrated to reduce susceptibility to SARS-CoV-2 infection in vitro and improve infection course in chronic liver diseases. However, real-life evidence is lacking. We analyzed the impact of UDCA on COVID-19 outcomes in patients hospitalized in a tertiary center. Be...
Autores principales: | Colapietro, Francesca, Angelotti, Giovanni, Masetti, Chiara, Shiffer, Dana, Pugliese, Nicola, De Nicola, Stella, Carella, Francesco, Desai, Antonio, Ormas, Monica, Calatroni, Marta, Omodei, Paolo, Ciccarelli, Michele, Aliberti, Stefano, Reggiani, Francesco, Bartoletti, Michele, Cecconi, Maurizio, Lleo, Ana, Aghemo, Alessio, Voza, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457973/ https://www.ncbi.nlm.nih.gov/pubmed/37632080 http://dx.doi.org/10.3390/v15081738 |
Ejemplares similares
-
Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life
por: Pugliese, Nicola, et al.
Publicado: (2023) -
Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy
por: Cecconi, Maurizio, et al.
Publicado: (2020) -
The effect of COVID-19 epidemic on vital signs in hospitalized patients: a pre-post heat-map study from a large teaching hospital
por: Caruso, Pier Francesco, et al.
Publicado: (2021) -
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy
por: Aghemo, Alessio, et al.
Publicado: (2020) -
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study
por: Laino, Maria Elena, et al.
Publicado: (2022)